no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review
|
Kalampokis, Ioannis |
|
|
50 |
4 |
p. 645-656 |
article |
2 |
Addressing the rheumatology workforce shortage: A multifaceted approach
|
Miloslavsky, Eli M. |
|
|
50 |
4 |
p. 791-796 |
article |
3 |
Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis
|
Chen, Shiju |
|
|
50 |
4 |
p. 534-543 |
article |
4 |
A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus
|
Chang, Joyce C. |
|
|
50 |
4 |
p. 527-533 |
article |
5 |
Assessment of damage in Takayasu‘s arteritis
|
Kaymaz-Tahra, Sema |
|
|
50 |
4 |
p. 586-591 |
article |
6 |
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
|
Torrente-Segarra, Vicenç |
|
|
50 |
4 |
p. 657-662 |
article |
7 |
Attaining CDAI remission is the first gateway to attain Boolean remission
|
Yoshii, Ichiro |
|
|
50 |
4 |
p. 624-626 |
article |
8 |
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
|
Dominguez-Casas, Lucia C. |
|
|
50 |
4 |
p. 608-615 |
article |
9 |
Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China
|
Chen, Yu |
|
|
50 |
4 |
p. 559-563 |
article |
10 |
Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study
|
Partington, Richard |
|
|
50 |
4 |
p. 663-672 |
article |
11 |
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study
|
Coates, Laura C. |
|
|
50 |
4 |
p. 709-718 |
article |
12 |
COVID-19 in rheumatic disease patients on immunosuppressive agents
|
Sharmeen, Saika |
|
|
50 |
4 |
p. 680-686 |
article |
13 |
Cryoglobulinemia after the era of chronic hepatitis C infection
|
Boleto, Gonçalo |
|
|
50 |
4 |
p. 695-700 |
article |
14 |
Cumulative patient-based disease activity monitoring in rheumatoid arthritis – predicts sustained remission, flare and treatment escalation
|
Leung, M.H. |
|
|
50 |
4 |
p. 749-758 |
article |
15 |
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission
|
Aletaha, Daniel |
|
|
50 |
4 |
p. 643-644 |
article |
16 |
Does type 2 diabetes increase the risk of musculoskeletal pain? Cross-sectional and longitudinal analyses of UK biobank data
|
Carvalho-e-Silva, Ana Paula |
|
|
50 |
4 |
p. 728-734 |
article |
17 |
Editorial Board
|
|
|
|
50 |
4 |
p. ii |
article |
18 |
Effectiveness of tocilizumab in Behcet's disease: A systematic literature review
|
Akiyama, Mitsuhiro |
|
|
50 |
4 |
p. 797-804 |
article |
19 |
Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review
|
Betrains, A |
|
|
50 |
4 |
p. 636-642 |
article |
20 |
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial
|
Molto, Anna |
|
|
50 |
4 |
p. 701-708 |
article |
21 |
High-density lipoprotein functionality in systemic lupus erythematosus
|
Ganjali, Shiva |
|
|
50 |
4 |
p. 769-775 |
article |
22 |
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
|
Michelena, Xabier |
|
|
50 |
4 |
p. 564-570 |
article |
23 |
Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis
|
Xie, Wenhui |
|
|
50 |
4 |
p. 598-607 |
article |
24 |
Intensive therapy alleviates subclinical synovitis on ultrasound and disease activity and reduces flare in rheumatoid arthritis patients who have achieved clinical target – a randomized controlled trial
|
Zhao, Juan |
|
|
50 |
4 |
p. 673-679 |
article |
25 |
Is Tocilizumab as efficient as steroids early in polymyalgia rheumatica?
|
Carvajal Alegria, Guillermo |
|
|
50 |
4 |
p. 582 |
article |
26 |
Mortality in psoriatic arthritis: Risk, causes of death, predictors for death
|
Elalouf, Ofir |
|
|
50 |
4 |
p. 571-575 |
article |
27 |
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group
|
Cai, Ken |
|
|
50 |
4 |
p. 719-727 |
article |
28 |
Patterns of clinical presentation in Takayasu's arteritis
|
Quinn, Kaitlin A. |
|
|
50 |
4 |
p. 576-581 |
article |
29 |
Publisher's Note
|
|
|
|
50 |
4 |
p. 812 |
article |
30 |
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease
|
Romero-Bueno, F. |
|
|
50 |
4 |
p. 776-790 |
article |
31 |
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study
|
Muratore, Francesco |
|
|
50 |
4 |
p. 549-558 |
article |
32 |
Safety of TNF inhibitors in rheumatic disease in case of NAFLD and cirrhosis
|
Verhoeven, Frank |
|
|
50 |
4 |
p. 544-548 |
article |
33 |
Serious adverse events in children with juvenile idiopathic arthritis and other rheumatic diseases on tocilizumab – a real-world experience
|
Aeschlimann, Florence A. |
|
|
50 |
4 |
p. 744-748 |
article |
34 |
The altered metabolism profile in pathogenesis of idiopathic inflammatory myopathies
|
Liu, Di |
|
|
50 |
4 |
p. 627-635 |
article |
35 |
The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States
|
Clarke, Ann E. |
|
|
50 |
4 |
p. 759-768 |
article |
36 |
The experience of a gout flare: a meta-synthesis of qualitative studies
|
Stewart, Sarah |
|
|
50 |
4 |
p. 805-811 |
article |
37 |
The patient global assessment in RA precludes the majority of patients otherwise in remission to reach this status in clinical practice. Should we continue to ignore this?
|
Ferreira, Ricardo J.O. |
|
|
50 |
4 |
p. 583-585 |
article |
38 |
Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort study
|
Romão, Vasco C. |
|
|
50 |
4 |
p. 735-743 |
article |
39 |
Understanding differences between men and women with axial spondyloarthritis
|
Wright, Grace C. |
|
|
50 |
4 |
p. 687-694 |
article |
40 |
Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis
|
Cho, Soo-Kyung |
|
|
50 |
4 |
p. 592-597 |
article |
41 |
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis
|
Nienhuis, Pieter H |
|
|
50 |
4 |
p. 616-623 |
article |